SD |
ejection fraction |
artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
cardiac output trait |
male |
0 days
| 6 |
75.0 |
% |
3.0 |
7.35 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
2 |
days |
98882 |
2160 |
SD |
ejection fraction |
sham surgical control condition (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
cardiac output trait |
male |
72 days
| 5 |
66.0 |
% |
3.0 |
6.71 |
echocardiography |
0.0 |
sham ACF |
2 |
days |
99371 |
2278 |
SD |
ejection fraction |
artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
cardiac output trait |
male |
0 days
| 6 |
65.0 |
% |
3.0 |
7.35 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
360 |
min |
98878 |
2160 |
SD |
ejection fraction |
artificial aortocaval fistula (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
cardiac output trait |
male |
72 days
| 5 |
76.0 |
% |
5.0 |
11.18 |
echocardiography |
0.0 |
ACF |
2 |
days |
99372 |
2278 |
SD |
ejection fraction |
sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
cardiac output trait |
male |
98 days
| 7 |
67.0 |
% |
2.0 |
5.29 |
echocardiography |
0.0 |
sham ACF |
28 |
days |
99377 |
2278 |
SD |
ejection fraction |
sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
cardiac output trait |
male |
0 days
| 6 |
65.0 |
% |
2.0 |
4.9 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
360 |
min |
98879 |
2160 |
SD |
ejection fraction |
artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
cardiac output trait |
male |
0 days
| 6 |
66.0 |
% |
4.0 |
9.8 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
720 |
min |
98880 |
2160 |
SD |
ejection fraction |
artificial aortocaval fistula (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
cardiac output trait |
male |
98 days
| 8 |
63.0 |
% |
2.0 |
5.66 |
echocardiography |
0.0 |
ACF |
28 |
days |
99376 |
2278 |
SD |
ejection fraction |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
cardiac output trait |
male |
98 days
| 7 |
66.0 |
% |
2.0 |
5.29 |
echocardiography |
0.0 |
sham ACF |
28 |
days |
99375 |
2278 |
SD |
ejection fraction |
sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
cardiac output trait |
male |
0 days
| 6 |
65.0 |
% |
3.0 |
7.35 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
2 |
days |
98883 |
2160 |
SD |
ejection fraction |
sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
cardiac output trait |
male |
0 days
| 6 |
64.0 |
% |
3.0 |
7.35 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
5 |
days |
98885 |
2160 |
SD |
ejection fraction |
sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
cardiac output trait |
male |
72 days
| 5 |
72.0 |
% |
2.0 |
4.47 |
echocardiography |
0.0 |
sham ACF |
2 |
days |
99373 |
2278 |
SD |
ejection fraction |
artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
cardiac output trait |
male |
98 days
| 8 |
71.0 |
% |
1.0 |
2.83 |
echocardiography |
0.0 |
ACF |
28 |
days |
99378 |
2278 |
SD |
ejection fraction |
sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
cardiac output trait |
male |
0 days
| 6 |
63.0 |
% |
3.0 |
7.35 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
720 |
min |
98881 |
2160 |
SD |
ejection fraction |
artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
cardiac output trait |
male |
0 days
| 6 |
75.0 |
% |
3.0 |
7.35 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
5 |
days |
98884 |
2160 |
SD |
ejection fraction |
artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
cardiac output trait |
male |
72 days
| 5 |
79.0 |
% |
3.0 |
6.71 |
echocardiography |
0.0 |
ACF |
2 |
days |
99374 |
2278 |